Cargando…
Understanding the role of Toll-like receptors in lung cancer immunity and immunotherapy
Lung cancer is currently the leading cause of cancer-related deaths worldwide. Significant improvements in lung cancer therapeutics have relied on a better understanding of lung cancer immunity and the development of novel immunotherapies, as best exemplified by the introduction of PD-1/PD-L1-based...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659925/ https://www.ncbi.nlm.nih.gov/pubmed/36389785 http://dx.doi.org/10.3389/fimmu.2022.1033483 |